FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Henning Flechtner

Research Profile

Concepts & Ideas

Disorders

Procedures

Chemicals & Drugs

Activities & Behaviors

Geographic Areas

Germany

Co-author Network

Publications

TOP 3
Joachim Weis; Markus Wirtz; Juan Ignacio Arraras; Thierry Conroy; Fabio Efficace; Henning Flechtner; Claudia Fleissner; Attila Görög; Eva Hammerlid; Bernhard Holzner; Louise Jones; Anne Lanceley; Susanne Singer; Andrew Bottomley
Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).
Kerstin Krauel; Nadine Krause-Hebecker; Andrea Simon; Andrew Bottomley; Agnes Czimbalmos; Henning Flechtner
When a parent has cancer: challenges to patients, their families and health providers.
John T Maringwa; Francesca Martinelli; David Osoba; Chantal Quinten; Bryce B Reeve; Jolie Ringash; Egbert F Smit; Martin J Taphoorn; Jan P van Meerbeeck; Jurgen Vercauteren; Joachim Weis; Andrew Bottomley; Charles S Cleeland; Corneel Coens; Henning Flechtner; Carolyn C Gotay; Elfriede Greimel; Madeleine King; Joseph Schmucker-Von Koch
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Henning Flechtner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Joachim Weis; Markus Wirtz; Juan Ignacio Arraras; Thierry Conroy; Fabio Efficace; Henning Flechtner; Claudia Fleissner; Attila Görög; Eva Hammerlid; Bernhard Holzner; Louise Jones; Anne Lanceley; Susanne Singer; Andrew Bottomley
Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).
Psycho-oncology 2013;22(5):1002-7.
2012: Kerstin Krauel; Nadine Krause-Hebecker; Andrea Simon; Andrew Bottomley; Agnes Czimbalmos; Henning Flechtner
When a parent has cancer: challenges to patients, their families and health providers.
Expert review of pharmacoeconomics & outcomes research 2012;12(6):795-808.
2011: John T Maringwa; Francesca Martinelli; David Osoba; Chantal Quinten; Bryce B Reeve; Jolie Ringash; Egbert F Smit; Martin J Taphoorn; Jan P van Meerbeeck; Jurgen Vercauteren; Joachim Weis; Andrew Bottomley; Charles S Cleeland; Corneel Coens; Henning Flechtner; Carolyn C Gotay; Elfriede Greimel; Madeleine King; Joseph Schmucker-Von Koch
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(11):1753-60.
2011: Francesca Martinelli; Tito Mendoza; David Osoba; Chantal Quinten; Bryce B Reeve; Jolie Ringash; Qiuling Shi; Martin J Taphoorn; Jurgen Vercauteren; Joachim Weis; andrew bottomley; Charles S Cleeland; Corneel Coens; Henning Flechtner; Carolyn C Gotay; Elfriede Greimel; Madeleine King; Joseph Schmucker-Von Koch; John T Maringwa
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
Expert review of pharmacoeconomics & outcomes research 2011;11(5):587-99.
2011: John Maringwa; F Martinelli; David Osoba; C Quinten; B B Reeve; J Ringash; J Schmucker-Von Koch; R Stupp; Martin J B Taphoorn; M J Van Den Bent; J Weis; andrew bottomley; Charles S Cleeland; Corneel Coens; Henning Flechtner; Carolyn C Gotay; Elfriede Greimel; M King
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(9):2107-12.
2007: Kathrin Sevecke; Maya K Krischer; P Walger; Gerd Lehmkuhl; Henning Flechtner
[Assessing psychopathic personality disorders for legal procedures for using a version for adolescents of Hare's revised checklist].
Der Nervenarzt 2007;78(5):552-9.
2005: Corneel Coens; andrew bottomley; Fabio Efficace; Henning Flechtner; Neil Aaronson
Variability and sample size requirements for health-related quality-of-life measures: understanding the challenges facing investigators.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8541-2; author reply 8542-3.
2005: andrew bottomley; Henning Flechtner; Fabio Efficace; Veerle Vanvoorden; Corneel Coens; Patrick Therasse; Galina Velikova; Jane M Blazeby; Elfriede Greimel
Health related quality of life outcomes in cancer clinical trials.
European journal of cancer (Oxford, England : 1990) 2005;41(12):1697-709.
2003: JU Rüffer; Henning Flechtner; P Tralls; Andreas Josting; Markus Sieber; Bernd Lathan; Volker Diehl
Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG).
European journal of cancer (Oxford, England : 1990) 2003;39(15):2179-86.
2003: Fabio Efficace; andrew bottomley; David Osoba; Carolyn C Gotay; Henning Flechtner; Sven D'haese; Alfredo Zurlo
Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3502-11.
2003: Jan-Peter Glossmann; Andreas Engert; G Wassmer; Henning Flechtner; Y Ko; C Rudolph; B Metzner; Bernd Dörken; S Wiedenmann; Volker Diehl; Andreas Josting
Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trial.
Annals of hematology 2003;82(8):469-75.
2003: Gerd Lehmkuhl; Henning Flechtner; Ulrike Lehmkuhl
[School refusal: classification, developmental psychopathology, prognosis and therapeutic approaches].
Praxis der Kinderpsychologie und Kinderpsychiatrie 2003;52(6):371-86.
2003: andrew bottomley; Ronald Thomas; Kristel van Steen; Henning Flechtner; Alexander de Graeff
Guidelines for the use of epoetin: have quality-of-life benefits been proven?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2223; author reply 2224-5.
2003: JU Rüffer; Henning Flechtner; M Heim; R Schwarz; J Weis
[Cancer fatigue syndrome].
Versicherungsmedizin / herausgegeben von Verband der Lebensversicherungs-Unternehmen e.V. und Verband der Privaten Krankenversicherung e.V 2003;55(1):3-7.
2003: andrew bottomley; Veerle Vanvoorden; Henning Flechtner; Patrick Therasse
The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials.
European journal of cancer (Oxford, England : 1990) 2003;39(3):275-85.
2003: Henning Flechtner; andrew bottomley
Fatigue and quality of life: lessons from the real world.
The oncologist 2003;8 Suppl 1():5-9.
2002: andrew bottomley; Ronald Thomas; Kristel van Steen; Henning Flechtner; Benjamin Djulbegovic
Erythropoietin improves quality of life--a response.
The lancet oncology 2002;3(9):527.
2002: andrew bottomley; S Vachalec; Kristin Bjordal; Jane M Blazeby; Henning Flechtner; P Ruyskart
The development and utilisation of the European Organisation for research and treatment of cancer quality of life group item bank.
European journal of cancer (Oxford, England : 1990) 2002;38(12):1611-4.
2002: andrew bottomley; Ronald Thomas; Kristel van Steen; Henning Flechtner; Benjamin Djulbegovic
Human recombinant erythropoietin and quality of life: a wonder drug or something to wonder about?
The lancet oncology 2002;3(3):145-53.
2002: Henning Flechtner; andrew bottomley
Fatigue assessment in cancer clinical trials.
Expert review of pharmacoeconomics & outcomes research 2002;2(1):67-76.
2002: Henning Flechtner; Karen Möller; Stephan Kranendonk; Stefan Luther; Gerd Lehmkuhl
[Subjective quality of life of children and adolescents with psychiatric disorders: development and validation of a new assessment scale].
Praxis der Kinderpsychologie und Kinderpsychiatrie 2002;51(2):77-91.
2001: Henning Flechtner
[Quality of life in oncological studies].
Onkologie 2001;24 Suppl 5():22-7.
2000: J C J M de Haes; Desmond Curran; T Young; andrew bottomley; Henning Flechtner; Neil Aaronson; Jane M Blazeby; Kristin Bjordal; Yvonne Brandberg; Elfriede Greimel; J Maher; Mirjam Sprangers; Ann Cull
Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group.
European journal of cancer (Oxford, England : 1990) 2000;36(7):821-5.
1998: Henning Flechtner; JU Rüffer; Michel Henry-Amar; W A Mellink; Markus Sieber; Christophe Fermé; Houchingue Eghbali; Andreas Josting; Volker Diehl
Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 5():S147-54.